| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/21/2011 | CN102190729A Anti-human CD80 bivalent dimer and application thereof |
| 09/21/2011 | CN102190728A Novel humanized anti-CD20 monoclonal antibody |
| 09/21/2011 | CN102190727A Monoclonal antibody, composition taking same as active ingredient, and application of monoclonal antibody |
| 09/21/2011 | CN102190726A Fab segment of human HIV antibody, and coding gene and application thereof |
| 09/21/2011 | CN102190725A Hand-foot-and-mouth disease resistant human immunoglobulin, and preparation and using methods and application thereof |
| 09/21/2011 | CN102190724A Chlordecone antigen and antibody and preparation method thereof |
| 09/21/2011 | CN102190723A Chromium ion antigen and preparation method and application thereof |
| 09/21/2011 | CN102188704A Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 09/21/2011 | CN102188449A Preparation method of high-immune whole-egg powder for resisting piglet diarrhea |
| 09/21/2011 | CN101705233B Recombinant human herpes simplex virus I protein HSV I gG and application thereof |
| 09/21/2011 | CN101475639B Mixed yolk antibody for preventing and treating duck infectious serositis and preparation thereof |
| 09/21/2011 | CN101165068B Monoclonal antibody for resisting HER2/ErbB2 antigen, preparation method and medicament composition thereof |
| 09/20/2011 | US8022190 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents |
| 09/20/2011 | US8022189 Isolated antibodies against biologically active leptin-related peptides |
| 09/20/2011 | US8022188 Immunosuppressant binding antibodies and methods of obtaining and using same |
| 09/20/2011 | US8022182 Truncated BAFF receptors |
| 09/20/2011 | US8022180 Method for preventing and treating Alzheimer's disease |
| 09/20/2011 | US8022174 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 09/20/2011 | US8022172 Clostridial toxin substrate comprising fluorphore, lanthanide donor complex and botulin toxin recognition sequence for use in detecting clostridial protease activity |
| 09/20/2011 | US8021879 Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof |
| 09/20/2011 | US8021878 Regulatory switches for controlling insect development; biological pest control |
| 09/20/2011 | US8021861 Pathogenic Escherichia coli associated protein |
| 09/20/2011 | US8021860 Method for producing human antibodies to a self physiological receptor by site-directed in vitro immunization of human lymphocytes |
| 09/20/2011 | US8021856 Transgenic cell for use as bioreactor in production of human estrogen receptor (HER) specific monoclonal antibody for use in targeted destruction of tumor cells |
| 09/20/2011 | US8021833 Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions |
| 09/20/2011 | US8021663 Antibodies to Lawsonia intracellularis |
| 09/20/2011 | US8021662 Microorganisms for therapy |
| 09/20/2011 | US8021661 Cripto binding molecules |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2488240C Solvent extraction of vitamin a and d from fluid samples and determination of the vitamin content by means of specific monoclonal antibodies |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2426348C Retrovirus isolated from humans |
| 09/20/2011 | CA2399832C Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2369848C Human endogenous retrovirus in breast cancer |
| 09/20/2011 | CA2356009C Vascular endothelial growth factor-x |
| 09/20/2011 | CA2347248C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 09/20/2011 | CA2329137C Novel tumor antigen useful in diagnosis and therapy of prostrate and colon cancer |
| 09/20/2011 | CA2319784C Methods for predicting pregnancy outcome in a subject by hcg assay |
| 09/20/2011 | CA2319700C Methods of identifying genes involved in enhanced wound healing in mice |
| 09/20/2011 | CA2217522C Isolated frpb nucleic acid molecule and vaccine |
| 09/15/2011 | WO2011112993A2 Methods of predicting and decreasing the risk of pregnancy loss |
| 09/15/2011 | WO2011112935A2 Antibody fusion proteins with disrupted heparin-binding activity |
| 09/15/2011 | WO2011112850A2 Humanized and chimeric anti-properdin antibodies |
| 09/15/2011 | WO2011112566A2 Basigin binding proteins |
| 09/15/2011 | WO2011112549A2 Temperature sensitive conjugate compositions, and uses related thereto |
| 09/15/2011 | WO2011111966A2 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| 09/15/2011 | WO2011111832A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
| 09/15/2011 | WO2011111820A1 Diagnostic marker for lung cancer or cervical cancer |
| 09/15/2011 | WO2011111698A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 09/15/2011 | WO2011111694A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 09/15/2011 | WO2011111392A1 Hjurp peptides and vaccines including the same |
| 09/15/2011 | WO2011110657A1 Specific detection of human chorionic gonadotropin beta subunit type ii produced by trophoblastic and neoplastic cells |
| 09/15/2011 | WO2011110621A1 Biological products: humanised agonistic anti-pd-1 antibodies |
| 09/15/2011 | WO2011110604A1 Pd-1 antibody |
| 09/15/2011 | WO2011110598A1 Method for purifying immunoglobulin solutions |
| 09/15/2011 | WO2011110515A1 Immunoglobulin g fc region binding polypeptide |
| 09/15/2011 | WO2011110490A1 Process for the production of radioactively labelled scfv antibody fragments, kits and compositions |
| 09/15/2011 | WO2011080765A3 Recombinant human bivalent diabody against rabies virus and uses thereof |
| 09/15/2011 | WO2011050071A3 Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography |
| 09/15/2011 | WO2011046309A3 A diagnostic marker for hepatocellular carcinoma comprising anti-fasn autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof |
| 09/15/2011 | WO2011034582A3 Hiv-1 antibodies |
| 09/15/2011 | WO2011012609A3 Anti - tgf - beta receptor type ii single domain antibodies |
| 09/15/2011 | WO2010104749A8 Antigen presenting cell targeted cancer vaccines |
| 09/15/2011 | US20110225682 Polynucleotides encoding caryophyllene synthase and uses thereof |
| 09/15/2011 | US20110224415 Human muty |
| 09/15/2011 | US20110224408 Treatment and prophylaxis of amyloidosis |
| 09/15/2011 | US20110224279 Anticancer agent |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224133 Highly Potent Peptides To Control Cancer And Neurodegenerative Diseases |
| 09/15/2011 | US20110224102 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/15/2011 | US20110223686 Protein production method, fusion protein, and antiserum |
| 09/15/2011 | US20110223684 Detection of specific nitrated markers |
| 09/15/2011 | US20110223658 Monoclonal antibodies with enhanced adcc function |
| 09/15/2011 | US20110223645 Multivalent Carriers of Bi-Specific Antibodies |
| 09/15/2011 | US20110223624 Immunoassay for detection of neurotoxic amino acid associated with neurological disorders |
| 09/15/2011 | US20110223615 Rapid Expression Cloning of Human Monoclonal Antibodies from Memory B Cells |
| 09/15/2011 | US20110223614 Toxin detection method |
| 09/15/2011 | US20110223611 Lenalidomide and thalidomide immunoassays |
| 09/15/2011 | US20110223597 Methods relating to olanzapine pharmacogenetics |
| 09/15/2011 | US20110223182 Monoclonal antibodies for treatment of cancer |
| 09/15/2011 | US20110223178 Antibodies That Specifically Bind to Chemokine Beta-4 |
| 09/15/2011 | US20110223177 Treatment of fibrotic eye disorders |
| 09/15/2011 | US20110223176 Basigin binding proteins |
| 09/15/2011 | US20110223175 Gene Encoding G-Protein Coupled Receptor And Gene Product Thereof |
| 09/15/2011 | US20110223174 Nontypeable Haemophilus Influenzae Virulence Factors |
| 09/15/2011 | US20110223173 Botulinum Neurotoxin A Receptor and the Use Thereof |
| 09/15/2011 | US20110223172 Soluble Forms of Hendra and Nipah Virus F Glycoprotein and Uses Thereof |
| 09/15/2011 | US20110223168 Ligand that has binding specificity for il-4 and/or il-13 |
| 09/15/2011 | US20110223167 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 09/15/2011 | US20110223165 Humanized C-Kit Antibody |
| 09/15/2011 | US20110223164 Binding domain-immunoglobulin fusion proteins |
| 09/15/2011 | US20110223163 Monoclonal antibodies that react with the capsule of bacillus anthracis |
| 09/15/2011 | US20110223160 Compositions and methods relating to glucagon receptor antibodies |
| 09/15/2011 | US20110223155 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/15/2011 | US20110223152 Use of inhibitors of leukotriene b4 receptor blt2 for treating human cancers |
| 09/15/2011 | US20110223133 Therapeutic agent for hematopoietic tumors |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | US20110223107 Antibodies that specifically block the biological activity of a tumor antigen |